{"database": "lobbying", "table": "lobbying_activities", "rows": [[2421977, "a7d506d3-b50b-443f-90e1-33cdbbe879aa", "Q1", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2020, "first_quarter", "MMM", "H.R. 748 - CARES Act - Issues related to supporting the national work fighting COVID-19 and ensuring that medication is available during the COVID-19 crisis and beyond.\n\nH.R. 6201 - Families First Coronavirus Response Act -  Issues related to ensuring that the federal government is best supporting public and private healthcare programs and providers.\n\nH.R. 6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020 - Issues related to supporting programs and institutions supporting during the current pandemic. \n\nHHS rules and regulations related  to the cost of prescription drugs, including, but not limited to,  limiting rebates in the Medicare and Medicaid prescription drug benefits.", "HOUSE OF REPRESENTATIVES,SENATE", 0, 0, "2020-04-08T10:20:04.430000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2421977"], "units": {}, "query_ms": 0.5334349989425391, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}